Foreword Michael S Ritsner\nContributors\nContent\nPart I. Neuroprotective Strategies and Mechanisms

The brain protection of patients with neuropsychiatric disorders. Ehud Susser, and Michael S. Ritsner

Towards a new paradigm in neuroprotection and neuroplasticity. Dafin F. Muresanu\nWhat protects patients with schizophrenia from developing Alzheimer pathology? Hans-Gert Bernstein, Theresia S. Ernst, Uwe Lendeckel, Henrik Dobrowolny, Johann Steiner, Bernhard Bogerts

Assessing neurodegeneration in vivo in schizophrenia using magnetic resonance. Jean Théberge

Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. Sarah J. Bailey and Peter J. McCaffery

Phosphatidylinositol 3-kinase/glycogen synthase kinase and mitogen-activated protein kinase signalling cascades in neuronal cell survival: What the neurotrophins have taught us, and implications for neuropsychiatric disorders. Stephen D. Skaper

One-compound-multi-targets at amyloid b cascade offered by bis(7)-Cognitin, a novel anti-Alzheimer\'s dimmer. Wenming Li, Hongjun Fu, Moussa B.H. Youdim, Yuanping Pang, Yifan Han

Common pathways to neurodegeneration and co-morbid depression. Darcy Litteljohn, Emily N. Mangano, and Shawn Hayley

Breakdown of the blood-brain barrier in stress alters cognitive dysfunction and induces brain pathology. New perspective for neuroprotective strategies. Hari S Sharma

Oxidative stress and neurodegeneration: An inevitable consequence of aging? Implications for therapy. Roberto Rodrigues, David J. Bonda, George Perry, Rudy J. Castellani, Gemma Casadesus, Hyoung-gon Lee, Hyun-Pil Lee, Xinglong Wang, Xiongwei Zhu, Robert B. Petersen, Mark A. Smith

Carbon nanotubes as electricalinterfaces with neurons. William Lee and Vladimir Parpura

Part II. Neuroprotective Treatment and Neuromodulation

Is a neuroprotective therapy suitable for schizophrenia patients? Michael S. Ritsner

Recombinant human erythropoietin: Novel approach to neuroprotection and neuroregeneration in schizophrenia. Hannelore Ehrenreich, Martin Begemann, Claudia Bartels and Henning Krampe

Neuroprotective agents in mood disorders: pathophysiological and therapeutic implications. Giacomo Salvadore, Husseini K Manji

Neuroprotection in bipolar disorder. Chris Aiken

New antiepileptic drugs in neuropsychiatric disorders - basic and clinical pharmacology. Cecilie Johannessen Landmark and Svein I. Johannessen

The neuroprotective efficacy of vitamins. Chanoch Miodownik, Vladimir Lerner

Smoking and mental disorders: Focus on neuroprotection. Tsafrir Loebl\nInhibitor of glycine transporter-1 improves the functional outcome of schizophrenia. Christina Hui, and Guochuan Emil Tsai

The role of oxytocin in neuropsychiatric disorders: Concepts and Mechanisms. Raz Levin, Shany Edelman, Idan Shalev, Richard P. Ebstein and Uriel Heresco-Levy

Neuromodulation for neuropsychiatric disorders: Novel techniques - Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation. Russell J Andrews

Index